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ABSTRACT
Purpose: Bearing partially or fully metallic passive implants represents an exclusion criterion for
patients undergoing a magnetic hyperthermia procedure, but there are no specific studies backing
this restrictive decision. This work assesses how the secondary magnetic field generated at the surface
of two common types of prostheses affects the safety and efficiency of magnetic hyperthermia treat-
ments of localized tumors. The paper also proposes the combination of a multi-criteria decision ana-
lysis and a graphical representation of calculated data as an initial screening during the preclinical risk
assessment for each patient.
Materials and methods: Heating of a hip joint and a dental implant during the treatment of
prostate, colorectal and head and neck tumors have been assessed considering different exter-
nal field conditions and exposure times. The Maxwell equations including the secondary field
produced by metallic prostheses have been solved numerically in a discretized computable
human model. The heat exchange problem has been solved through a modified version of the
Pennes’ bioheat equation assuming a temperature dependency of blood perfusion and meta-
bolic heat, i.e. thermorregulation. The degree of risk has been assessed using a risk index with
parameters coming from custom graphs plotting the specific absorption rate (SAR) vs tempera-
ture increase, and coefficients derived from a multi-criteria decision analysis performed follow-
ing the MACBETH approach.
Results: The comparison of two common biomaterials for passive implants - Ti6Al4V and CoCrMo
- shows that both specific absorption rate (SAR) and local temperature increase are found to be
higher for the hip prosthesis made by Ti6Al4V despite its lower electrical and thermal conductiv-
ity. By tracking the time evolution of temperature upon field application, it has been established
that there is a 30 s delay between the time point for which the thermal equilibrium is reached at
prostheses and tissues. Likewise, damage may appear in those tissues adjacent to the prostheses
at initial stages of treatment, since recommended thermal thresholds are soon surpassed for
higher field intensities. However, it has also been found that under some operational conditions
the typical safety rule of staying below or attain a maximum temperature increase or SAR value
is met.
Conclusion: The current exclusion criterion for implant-bearing patients in magnetic hyperthermia
should be revised, since it may be too restrictive for a range of the typical field conditions used.
Systematic in silico treatment planning using the proposed methodology after a well-focused
diagnostic procedure can aid the clinical staff to find the appropriate limits for a safe treatment
window.
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Magnetic hyperthermia has already been tested in clinical
settings as an adjuvant to radiotherapy to successfully treat
several types of tumors [1–3], especially glioblastoma multi-
forme. Beyond its use for inducing thermal damage and/or
sensitizing tumors to first-line treatments, the heat implied in
magnetic hyperthermia is also used to control the activation
or the release of anticancer drugs [4,5] and to complement
diagnostic techniques [6] into what is known as cancer thera-
nostics, although these approaches are still a further step
back from clinical studies due to the more complex regula-
tory process involved. The increase of more specialized
instrumental development is relentless, and commercial sys-
tems are being deployed in Europe and USA; hence, research
on safety, dosimetry and treatment planning should progress
at the same pace. The therapy must be adapted to each
patient and tumor, as well as to the evolution of the tumor
throughout the process. In this regard, the development of
virtual models of tumors from diagnostic data and the per-
formance of computer simulations allow to improve the
planning and execution of treatments and the predictions of
the behavior of each tumor [7,8]. In the specific case of mag-
netic hyperthermia, the only data on simulations applied to
clinical trials date back from the early 2000s [9–11]. These
studies laid the foundations for treatment planning of mag-
netic hyperthermia in humans. In this context, the presence
nearby the region of interest of passive irremovable metallic
implants, like dental fillings, staples or orthopedic prostheses,
constitutes an exclusion criterion in the available data on
these clinical trials [12,13]. The core biomaterials for these
implants are metallic or have metallic components – typically
Ti6Al4V and, to a lesser extent since 2013, CoCrMo, due to
some biocompatibility issues [14,15] – with electrical con-
ductivity much higher than the one of the surrounding
human tissues. These components, when exposed to the
alternating magnetic fields (AMF), develop significant
induced currents (eddy currents) that circulate mainly in prox-
imity of their surface and create a secondary magnetic field
counteracting the former. In addition, such eddy currents
produce into the metallic components power dissipation
(Joule losses), which translates into a temperature rise that
diffuses to the surrounding tissues, leading to potential ther-
mal damages [16]. This aspect is of particular interest given
how often this kind of implants is found in prospective
patients of the aforementioned techniques. Since only in the
USA it was estimated that 7,2 million people were living with
a joint implant back in 2014 [17], the probability of finding a
prospective magnetic hyperthermia patient wearing a pas-
sive implant is relatively high. While receiving some attention
in magnetic resonance imaging, for both radiofrequency and
gradient coil signals [18–25], to date neither computational,
nor experimental studies have been carried out on eddy cur-
rent heating of implants as a side effect of magnetic hyper-
thermia treatments. Instead, up to now in the hyperthermia
context the eddy current heating of implants comes from
the use of some ferromagnetic electrodes or ‘thermal seeds’
(which could be here regarded as passive implants for the
sake of comparison) that have been the active part of some
other invasive hyperthermia modalities [26–28]. Perhaps, the
lack of studies explains why the presence of metallic pros-
theses constitutes an exclusion criterion, as per the informa-
tion available in relevant clinical trials registered in public
databases [29].
As regards to direct thermal effects on native biological
tissues, since 1998 the International Commission on Non-
Ionizing Radiation Protection (ICNIRP) has recommended
basic restrictions on the specific absorption rate (SAR), for
frequency values above 100 kHz. Reference levels expressed
in terms of unperturbed field quantities were established by
ICNIRP as well [30].
These recommended thresholds have been questioned
and revisited [31] due to the unclear implicit safety factors
that may be preventing access to a wider range of field con-
ditions in hyperthermia treatments. Certainly, the fact that
higher frequencies (f) and magnetic field intensity (H) values
could be employed, depending on the body region to treat,
was pointed out by Stauffer et al. [32] and recognized by
Atkinson et al. in their overall Hf threshold proposition [26].
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The recently published 2020 ICNIRP Guidelines for Limiting
Exposure to Electromagnetic Fields [33], which have updated
the radiofrequency electromagnetic (EM) field part of the
ICNIRP 1998 guidelines [30], and the 100 kHz to 10MHz part
of the ICNIRP (2010) low frequency guidelines [34,35] have
defined new safety criteria and, consequently, new reference
values. In particular, for occupational exposure the guidelines
take a local SAR (i.e., specific absorption rate averaged over
10g of contiguous tissue in every 6-min interval) in the head
and torso of 10Wkg1 as the local exposure level corre-
sponding to the adverse thermal health effect threshold. Such
a threshold is set to 5 C for Type-1 tissues (e.g., fat, muscle,
and bone) and to 2 C for Type-2 tissues (e.g., all tissues in
the head, abdomen, thorax, and pelvis not already included in
Type-1). The SAR value already includes an appropriate safety
factor to account for scientific uncertainty, as well as differen-
ces in thermal physiology across the population and variability
in environmental conditions and physical activity levels.
Some methodology have been proposed to reduce tissue
exposition to the external field in a study combining computer
modeling and a proof-of-concept experimentation on a breast
tumor phantom [36]. The proposed solution essentially com-
prises a coil displacement with respect to the tissues, aiming to
control the formation of induced currents and consequently of
hot spots, over the treated tissue. Although physically sound
and feasible, these methods are still of limited application to
deep-seated tumors due to the limited control on the field
homogeneity over the region of interest and the required
energy deposition to achieve a clinically effective heating.
Besides, the influence on implants is yet to be studied.
The present work focuses on the collateral heating due to
eddy currents induced in two largely prevalent categories of
passive implants, dental implant and hip prosthesis, whose
location typically matches that of some superficial tumors
(head and neck) or deeper ones (prostate and colorectal).
The obtained results question the current practice of consid-
ering implants as an exclusion criterion in clinical magnetic
hyperthermia, since under many operational conditions the
typical safety rule of staying below or attain a maximum
temperature increase or SAR value is met, even considering
the worst-case scenario. We propose the use of in silico treat-
ment planning methods to assess the extent of eddy cur-
rents in passive implants and to evaluate whether or not
they should be mitigated without compromising the field
conditions needed for an effective therapy.
2. Materials and methods
Far from the tumor, the temperature increase induced by
the exposure to the magnetic field is expected to be limited
during a safe treatment. Hence, it should not be able to alter
the electric properties of any relevant material significantly.
Based on this assumption, the analysis of the eddy current
heating of passive implants and surrounding tissues has
been divided into two subsequent steps. First the electro-
magnetic problem is solved, to determine the eddy current
distribution and power released. Then the thermal problem
is studied to estimate the consequent temperature increase
in tissues. In some case, the simulations predict a very large
heating, which disproves the assumptions explained above.
In such cases, the important point is that a potentially dan-
gerous situation, which must be avoided, has been clearly
found, even though the numerical value of the heating has a
low accuracy.
In the electromagnetic problem, the interaction between
the magnetic field generated by the sources (i.e., the coils
used for the hyperthermia treatment) and any conductive
medium (biological tissues and metallic objects) is studied by
solving numerically the electromagnetic Maxwell equations.
The secondary magnetic field Hi, generated by the currents
induced in the radiated body, sums to the unperturbed
source field Hs, giving rise to the total magnetic field H.
Formally, this fact results in
curl E ¼ l0
oH
ot
H ¼ Hs þ Hi
curlHi ¼ rE
(1)
where H(x,y,z,t) is the total magnetic field, function of the
spatial coordinates x, y, z and the time t, E(x,y,z,t) is the
induced electric field, r is the local electrical conductivity,
and l0 is the vacuum permeability. In low to medium
frequency electromagnetic dosimetry (e.g., when the compli-
ance with ICNIRP basic restrictions has to be verified to avoid
unintentional nerve stimulation, from 1Hz to 10MHz), the
secondary field can be disregarded when only native tissues
are studied. This assumption is implemented in commercially
available software for dosimetric analysis using highly
detailed anatomical human models (e.g., Sim4Life [37]).
However, in the presence of highly conducting elements (as
the metallic implants), significant eddy currents produce sec-
ondary fields strong enough to alter the local magnetic field
generated by the sources. This has a significant effect on the
intensity and the spatial distribution of the eddy currents,
and modifies the power deposition in the implant itself.
The presence of the secondary field Hi makes the numer-
ical solution of Equation (1) more complex with respect to
the case when Hi is disregarded. In the adopted approach,
the solution is obtained by introducing vector and scalar
potentials as unknowns instead of the fields and by discretiz-
ing the resulting equations with a hybrid finite element–
boundary element method (FEM–BEM) [38]. The problem is
formulated in frequency domain, where the unknowns are
phasors (complex quantities). The human model (with the
inserted implant) is the computational domain discretized in
voxels. Details of the numerical implementation are
described in [38,39] and briefly recalled in the
Supplementary Appendix A. The electromagnetic solver has
been extensively tested by comparison with laboratory meas-
urements on a phantom [40].
The second step of the procedure here adopted requires
the solution of the thermal problem described by Pennes’
bioheat equation [41]:
qcpoT=ot ¼ r  krT þ hb Tb  Tð Þ þ Pmet þ Pem (2)
where qcp is the volumetric heat capacity, k is the thermal
conductivity, hb is the blood perfusion coefficient in the
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human tissues, Tb is the temperature of blood, Pmet is the
volume power density associated with the metabolic process,
and Pem is the volume power density dissipated within the
metallic objects. The latter value is computed in each voxel
of the implant, starting from the previous electromagnetic
solution:
Pem ¼ r Ej j2=2
being r the electrical conductivity of the metal and E the
peak value of the electric field. On the body surface (oV, with
outward normal unit vector n), Robin boundary conditions
model the heat exchange with the external environment
(supposed to be at the constant temperature Tair ¼ 25 C)
Formally, by assuming a given heat exchange coefficient
hamb (hamb  7W/(m2K)), this can be expressed as
koT=on oV ¼ hamb T  Tairð Þj (3)
Thermoregulation processes are introduced in the thermal
model by assuming that the perfusion coefficient hb and the
metabolic heat Pem are dependent on temperature, as pro-
posed in [42]. Therefore, hb ¼ LB hb0, where LB ¼ 2(T-T0)/DB is
the local temperature-dependent multiplier (for T > T0),
being hb0 the perfusion coefficient at the rest temperature T0
and coefficient DB is set to 1.6 K. LB was limited to 15 for all
tissues except for skin, in which case the limit was 32.
Analogously, Pmet ¼ Lmet Pmet0, being factor Lmet ¼ 1.1(T-T0)
and Pmet0 the metabolic heat at rest. This is an approximated
model of the complex thermoregulation phenomena, which
disregards the response times of the thermoregulatory pro-
cess that regulates the core body and assumes an instantan-
eous regulation; in any case, it is considered appropriate for
local temperature increase. It must be remarked that this
model is valid for mild temperature increases, while it fails to
represent the physiological behavior in the presence of
strong heating and the related temperature increase. This
consideration explains why the results for some combina-
tions of implant and field intensity are not explicitely
reported in the next tables.
The determination of the temperature evolution described
by Equations (2) and (3) requires the knowledge of the spa-
tial distribution of the temperature before the electromag-
netic exposure (T0), determined by the metabolic heat and
the diffusion-perfusion phenomena, and the temperature of
blood (Tb). Since we are interested in the temperature eleva-
tion caused by the exposure to an electromagnetic field, the
thermal problem is here handled by introducing the tem-
perature elevation DT with respect to T0 as unknown (DT¼ T
- T0), so that the problem can be rewritten as
qcpo DTð Þ=ot ¼ r  kr DTð Þ½   2DT=DBhb0DT þ 1:1DT  1ð ÞPmet0
þ Pem
(4)
with Robin boundary conditions
ko DTð Þ=on oV ¼ hamb DTð Þ:


The thermal problem (Equation 4) is solved by a finite dif-
ference method (FDM) using Douglas–Gunn (DG) time split
scheme in a domain including both the implant and the
human body. The characteristics of the DG algorithm allow a
parallel implementation on GPUs. Details of the numerical
implementation can be found in [24], together with its valid-
ation in comparison with Semcad X software.
The numerical simulations were carried out using the
‘Duke’ model, a high-resolution healthy male human model
developed by the IT’IS Foundation [43] as part of the Virtual
Family computational models [44]. The original version of
this model includes about 80 different tissues, whose electric
and thermal properties have been set according to the data-
base of the IT’IS Foundation [45,46]. As discussed in
Supplementary Appendix B, the computational domain is
limited to a suitable portion of the human model, by taking
advantage of the local nature of the heating induced by the
dissipated power into the metallic objects. A wide range of
passive implants can be encountered in the clinical environ-
ment and could be suitable for this study. From all the pos-
sible designs and purposes, two exemplary kinds of
prostheses were selected: a hip prosthesis for total joint
replacement and a dental implant used to supply the
absence of a dental piece. These two implants were chosen
due to their high prevalence and to their location in the
body. The first one is placed in an inner part of the body,
considering it a deep-seated prosthesis, whereas the dental
implant is found in a superficial area of the head, making it
a shallow prosthesis. For the hip implant study, the human
model was truncated including both hips with height from
the anterior inferior iliac spine to 15 cm downwards from the
greater trochanter, leaving the prosthesis centered in the z
axis. In the simulations involving the dental implant, the
human phantom included the head and the neck up to the
height of the T2 vertebra. The shoulders were cut off follow-
ing the midclavicular line on both sides.
The 3D models of the investigated implants were placed
inside the healthy human model Duke in their anatomical
positions. Both prosthesis models were downloaded from
GRABCAD community [46,47] and adapted to the human
model using the open source 3D creation suite Blender [48]
to reproduce, as close as possible, the real clinical situation.
This adjustment consisted on minimal deformations in small
areas of the implant models to avoid some undesired over-
lapping between the tissues and the inserted objects without
losing its original design.
The hip model was placed in the right femur. The model
of this bone was also modified mimicking how it is sectioned
during a total hip replacement surgery, where the head of
the femur is cut and the stem of the implant is introduced
inside the bone.
For the dental implant, the procedure was simpler, since
the implant consists of a screw that is introduced in the
bone once the dental alveolus is naturally occupied again
with new bone tissue. To virtually reproduce this process,
the socket in the mandibular bone that corresponds to the
dental piece 36 was filled with cortical bone. The roots of
the piece were cut and the remaining part was used as a
model for the ceramic crown for the implant. The screw of
the prosthesis was placed in the bone by overlapping it to
the models.
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In order to check the idea that the position of the coil
with respect to the metallic part is crucial to decide whether
the therapy is safe or not for a specific patient, the electro-
magnetic field was studied placing the source in three differ-
ent regions of the human model. Two of them were the two
clinical cases explained before. In a third scenario, that we
have defined as the ‘worst-case scenario,’ the coil was placed
as close as possible to the prosthesis.
The field applicator considered for the hip prosthesis sim-
ulations is a generic flat, round, multiturn (often referred as
‘pancake’) coil, which has been placed in front of the areas
where theoretical colon and prostate tumors might be. The
applicator can impose a magnetic flux density of about 5mT,
10mT or 15mT in the area where these lesions would be
treated. However, given the linearity of the governing equa-
tions of the electromagnetic model, the results obtained in
this way can be scaled, quadratically, to any amplitude
adopted during interventions, provided that thermoregula-
tion processes are disregarded. Even though the worst-case
scenario is an improbable setup in the clinical environment,
it will help us to better understand how the variation of the
field reaching the prosthesis depends on the coil position.
For this comparison, the set of field intensity values tested in
the three cases were 5mT, 10mT and 15mT at the theoret-
ical tumor considered in each case. Besides safety reasons,
these field intensity values have been chosen considering
the experimental conditions met in numerous in vitro and
in vivo studies [49,50]. In particular, most of the magnetic
Figure 1. (i) Virtual models used for each of the considered cases, indicating the position of prostheses and coils (white hairlines): (a) head-and-neck, (b) colorectal,
(c) prostate, and (d) worst-case scenario tumor locations. For (a) a 3-turn open collar-type coil has been considered, while for (b), (c) and (d) a 3-turn (inner turn of
5 cm, intermediate turn 10 cm, and outer turn of 15 cm) non-spiral, single layer, flat air coil has been used instead. For comparison purposes, prostheses are made
of either Ti6Al4V or CoCrMo alloys in all the indications. (ii) Portion of voxels in the surrounding of each prosthesis that are taken into account for the scatter plot
analysis. (iii) Detail of the coil used for CR, Pr and WCS tumor locations. Dimensions are presented in mm. (iv) Detail of the coil used for NH tumor location.
Dimensions are presented in mm.
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colloids intended for magnetic hyperthermia usually heat
above 43 C for intensities below 30mT and frequencies
within 100–300 kHz for variable application times [49].
The field applicator considered for the dental implant is a
3-turn open collar-type coil adapted to the shape of the
patient’s neck. Unlike other non-portable devices approved
for use in humans [51], these generic field applicators are as
portable as those considered for ongoing clinical trials [52].
The main advantage of this type of coils is that the field is
projected over the patient and can be adapted to virtually
any region. Only one position of the coil has been consid-
ered, assuming a 5mT, 10mT and 15mT magnetic flux dens-
ity in the neck, specifically in the region where a superficial
tumor would be located. It is expected that patients bearing
a dental implant will also have a metal ceramic crown
screwed to it to make up for the lack of the dental piece.
Since this partially metallic object can be easily removed,
both cases with and without crown have been compared.
Figure 1 shows the hip and dental prostheses included
inside the human model together with the position of the
field applicator for neck, colon, prostate and worst-case scen-
ario, from left to right. In this figure, the implants are also
presented with the test volumes where the analyses are per-
formed and a detailed description of the coils used as appli-
cators is provided.
The resulting model of a patient carrying the implants
were discretized with cubic voxels following a homogeneous
grid with spatial resolution 2mm  2mm  2mm for the
hip prosthesis and 0.5mm  0.5mm  0.5mm in the case
of the dental implant. The stability of the results was prelim-
inarily verified by increasing the spatial discretization until
the unavoidable error in the approximated total power is
considered acceptable, according to the approach presented
in [53], where an experimental comparison was available.
Further information about gridding can be found in
Supplementary Appendix B, where the approach adopted to
face the problem of the ‘skin effect’ in metals is
also described.
The present study considers two of the most common
alloys used in hip prosthesis (CoCrMo and Ti6Al4V), which
have excellent mechanical characteristics [54]. The same
titanium alloy was adopted for the dental screw, while a typ-
ical metal-ceramic used in dental prosthetics was the crown
material. Electrical and thermal properties of the adopted
materials are summarized in Table 1.
The analysis was always performed assuming sinusoidal
supply conditions at the frequency of 300 kHz, within the
range intended for hyperthermia treatments. About this, it
must be pointed out that the skin effect occurring in metallic
components with high electric conductivity can alter the
quadratic dependence of the energy deposited in the tissue
by the AMF on the frequency and therefore the overall
proposed Hf threshold is no longer rigorously valid. Thus,
the results here presented are valid for a frequency range of
around 300 kHz, but cannot be straightforwardly extended to
considerably different frequency values.
Finally, the software M-MACBETH [58] was used to per-
form the Measuring Attractiveness by a Categorical Based
Evaluation Technique (MACBETH) to evaluate the coefficients
of the risk index equation described in section 3.1 (further
information can be found in Supplementary Appendix C).
3. Results
3.1. Sar vs DT log-log graphs
There is still debate on whether SAR or temperature should
be used as a metric for dosimetry and in which cases. Many
estimations have been done so far on a possible relationship
between SAR and temperature (see for example [59,60]),
mainly in the megahertz–gigahertz frequency range, more
specifically with reference to magnetic resonance imaging
and other hyperthermia modalities . This correlation has
been barely studied in the kilohertz range [61] and deserves
immediate attention for medical technology operating in
that frequency range, not only for magnetic hyperthermia,
but also for other next-generation techniques like magnetic
particle imaging [62,63].
In the present work, two quantities were assumed as
safety indicators: the distributions of both SAR and tempera-
ture increase (DT) evaluated after 5 and 30min of continuous
exposition in a test volume around the prosthesis. The tested
volume for both kinds of prostheses is the portion of paral-
lelepiped shown in Figure 1(ii) where the volumes taken up
by the implants have been removed. The boundaries of the
test volumes are chosen so that no variation of the externally
applied field with the secondary field generated by the eddy
currents in the prosthesis is observed. For the resulting rep-
resentation (Figures 2 and 4 and figures in Supplementary
Appendix D), each tissue voxel (excluding the implant voxels)
belonging to the test region is associated with the couple of
corresponding values of SAR and DT and displayed in a log-
log graph with DT as abscissa and SAR as ordinate. The scat-
ter plots are divided into four quadrants by the vertical and
horizontal lines. The horizontal line is associated with the
safety thresholds for SAR, which is 10W/kg assuming for
patients the same basic restriction on local SAR defined in
ICNIRP 2020 for occupational exposure. The vertical line is
associated with the threshold DT¼ 5 C according to ICNIRP
2020 guidelines [33] to set basic restrictions against thermal
effects of electromagnetic exposure. The corresponding
graphs considering 1 C as DT threshold following IEEE rec-
ommendations [64,65] can be found in [66].
The first quadrant A (lower left) of the SAR vs DT scatter
plots (Figure 2) includes the voxels whose values are below
the aforementioned SAR and DT thresholds, thus, satisfying
the recommendations done by ICNIRP/IEEE for electromag-
netic field exposures of living beings. The second quadrant B
(upper left) contains the voxels where SAR values overcome
the safety limit (SAR ‘hot spots’), but, because of the effects
of blood perfusion and diffusion parameters, the temperature
Table 1. Electrical and thermal properties of the implant materials used in
the simulations.
Material r ðkS=mÞ q ðkg=m3Þ cp ðJ=ðkg  KÞÞ kðW=ðm  KÞÞ
Ti6Al4V [55] 560 4430 526.3 6.7
Metal-ceramic [56,57] 0.16 8400 450 13
CoCrMo [57] 1160 8400 450 13
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rise remains below the threshold. It is known that high SAR
values do not necessarily imply a high biological effect;
moreover, low SAR values may have larger biological effects
than higher ones in certain cases [67]. Consequently, quad-
rant B may also contain voxels of tissues bearing a low haz-
ard potential despite their high SAR values. The voxels in the
third quadrant C (lower right) show SAR values below the
threshold, but overcome the limit established for the tem-
perature increase. Most of the voxels in this quadrant move
back to the first one A when the simulations are carried out
without prostheses. Since the low SAR values do not justify
in itself the temperature increase, the warming of these vox-
els can be attributed to the heat produced in the metallic
components of the prostheses and diffused in the
surrounding tissues. In order to validate this hypothesis, a
simple verification based on two steps simulations was pre-
pared. The thermal problem was solved twice, first nullifying
the SAR values of the tissue voxels (solution 1), and succes-
sively nullifying the electromagnetic power dissipated in the
prosthesis voxels (solution 2). These results are finally com-
pared against the complete simulation. The comparison con-
firmed the previous hypothesis, showing that the highest
contribution in DT comes from the heat produced in the
prosthesis and diffused in the surrounding tissues. Further
information regarding these solutions can be found in
Supplementary Appendix E. Finally, the last quadrant D
(upper right), collects the voxels where both SAR and DT
thresholds are trespassed.
Figure 2. Log-log scatter plots of DT versus SAR for bone voxels at f¼ 300 kHz with magnetic flux density of 15mT without accounting for thermoregulation. The
figures in the right column refer to colon tumor, the one in the left column to prostate tumor. Color varies depending on the distance of each voxel to its closest
point in the coil (reddish points are closer to the coil and bluish points are farther from it). The thresholds are established according to ICNIRP 2020 guidelines for
type 1 tissues, namely DT¼ 5 C and SAR ¼ 10W/kg.
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Additionally, a table shows the percentage of voxels
belonging to each quadrant. This compact quantitative rep-
resentation of the results can be used as a simplified version
of some of the most common multivariate decision tools
adopted in the clinical environment [68]. We propose a set
of parameters according to the risk inherent to each quad-
rant due to the different physiological effects depending on
the range of temperature increase [69]. A rough risk index,
but sufficient for the aim of this study, is obtained by com-
bining these parameters with the voxel distribution into the
quadrants, as in the following Equation (5):
risk index ¼ 0:0555  Aþ 0:1165  Bþ 0:4439  Cþ 0:5199  D,
(5)
being A, B, C and D the percentage of voxels in the corre-
sponding quadrant. The numerical coefficients multiplying A,
B, C and D are decimal fractions derived from a multi-criteria
decision analysis (MCDA) that is described in Supplementary
Appendix C. For the present case we have adopted the
Measuring Attractiveness by a Categorical Based Evaluation
Technique (MACBETH) [70], which is a pairwise comparisons
method aimed to judge the difference of attractiveness
between different options (the quadrants of the proposed
SAR vs DT log-log graphs) using a set of relevant criteria. The
latter were partially based on similar analysis made on drugs
for treating metastatic cancers [71,72], on the current ICNIRP
guidelines [33], on evidences from in vitro and in vivo testing
of thermal damage [73–75] and also on the available clinical
data on magnetic hyperthermia treatments of prostate can-
cer [1,2,76].
The scatter plots and the associated table to each plot are
found to be a useful tool to quickly estimate the harmful
potential of each treatment situation, able to put in evidence
the presence of excess power deposition (i.e., SAR and DT
hot spots), which cannot be evaluated only considering the
whole-body SAR. Each risk index is associated to a color tag
which corresponds to a range determining the severity of the
situation. These ranges are: a) Safe (S) in green with risk index
<0.1; b) Acceptable (A) in yellow with risk index 0.1 and
<0.15; c) Risky (R) in red with risk index 0.15 and <0.3,
and d) Very Risky (VR) with risk index 0.3. The thresholds
have been chosen considering the literature on similar indica-
tions and general effects of heat on tissues [73–76].
3.2. Analysis of the hip prosthesis
The results obtained in the evaluation of the effects pro-
duced in bone tissue within the control volume around a hip
prosthesis, considering both colon and prostate scenarios
and both materials (CoCrMo and Ti6Al4V alloys), are pre-
sented in Figure 2, Supplementary Figures S3 and S4 and
Table 2 in comparison with the case without prosthesis.
Here, the temperature increases were estimated neglecting
the thermoregulatory effects (i.e., hyperemia or vasodilation,
variation of metabolic heating, sweating [77]). After 5min of
exposure, extremely large temperature increases (over 30 C)
are already observed.
The data obtained from the colorectal simulations without
thermoregulation were compared with the results obtained
accounting for thermoregulation under the same magnetic
Table 2. Percentage of bone tissue voxels that land in each quadrant for fields of 5, 10 and 15mT in the tumor region for each case for both 5- and 30-
min exposure.




A B C D A B C D Risk
5mT CR CoCrMo 100.00% 0.00% 0.00% 0.00% 0.06 (S) 99.21% 0.00% 0.79% 0.00% 0.06 (S)
CR Ti6Al4V 99.27% 0.00% 0.73% 0.00% 0.06 (S) 95.58% 0.00% 4.42% 0.00% 0.07 (S)
CR without prosthesis 100.00% 0.00% 0.00% 0.00% 0.06 (S) 100.00% 0.00% 0.00% 0.00% 0.06 (S)
Pr CoCrMo 78.61% 0.00% 21.17% 0.22% 0.14 (A) 71.69% 0.00% 28.09% 0.22% 0.17 (R)










Pr without prosthesis 99.99% 0.01% 0.00% 0.00% 0.06 (S) 99.99% 0.01% 0.00% 0.00% 0.06 (S)
10mT CR CoCrMo 90.15% 0.00% 9.84% 0.00% 0.09 (S) 80.68% 0.00% 19.31% 0.00% 0.13 (A)
CR Ti6Al4V 82.03% 0.00% 17.95% 0.02% 0.13 (A) 75.89% 0.00% 24.09% 0.02% 0.15 (R)
CR without prosthesis 99.94% 0.06% 0.00% 0.00% 0.06 (S) 99.94% 0.06% 0.00% 0.00% 0.06 (S)








































Pr without prosthesis 87.73% 12.27% 0.00% 0.00% 0.06 (S) 87.73% 12.27% 0.00% 0.00% 0.06 (S)
15mT CR CoCrMo 75.60% 0.02% 24.25% 0.14% 0.15 (R) 67.71% 0.02% 32.13% 0.14% 0.18 (R)
CR Ti6Al4V 68.73% 0.04% 30.99% 0.25% 0.18 (R) 63.29% 0.04% 36.43% 0.25% 0.20 (R)
CR without prosthesis 99.47% 0.53% 0.00% 0.00% 0.06 (S) 99.47% 0.53% 0.00% 0.00% 0.06 (S)




























































Risk column color indicates the safety of each case according to Equation (5), the darker, the riskier; and a letter that indicates the risk: (S), safe; (A), acceptable;
(R), risky; (VR), very risky. Note that results presented for Pr Ti6AlV at 5mT shown in bold italics are after 2min exposure instead of 5. This corresponds to the
last instant the thermoregulation model retrieves.
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flux densities: 5mT, 10mT and 15mT (Supplementary Figure
S3). This comparison showed that the thermoregulatory
effects reduce the temperature increase. In the colon case,
the maximum temperature rise in bone tissue drops from
77.68 C to 60.85 C in the Ti6Al4V hip implant and from
37.10 C to 35.12 C in the CoCrMo prosthesis under a 15mT
field. For simulations in the prostate case, the adopted
numerical solver of the non-linear thermal problem required
a too fine time discretization to provide a good approxima-
tion of the temperature increase. The data corresponding to
these simulations are shown in Table 2 and Supplementary
Table S7 as ‘Out of range.’ On the other hand, the heating
predicted for prostate simulations without thermoregulation
is very large and, as mentioned in Section 2, disproves a pos-
teriori the assumptions at the foundation of the computa-
tional scheme. Nevertheless, the obtained results are still
relevant, because high temperatures, and therefore unsafe
conditions, are undoubtedly identified. Further information
regarding other relevant tissues in the hip test volume, such
as fat and muscle, are presented in Supplementary Appendix
D, Tables S8 and S9 and in Ref. [66].
The calculated data reveal how the presence of the hip
implant always enhances the risk for the patients. The num-
ber of voxels belonging to the ‘safe’ quadrant A significantly
reduces for the major tissues studied, mainly for the bone,
which is in intimate contact the metallic object. This result,
although it cannot be generalized since it is limited to the
adopted conditions, seems to partially justify the exclusion
criterion for the patient with metallic prosthesis in most, but
not all, cases. For example, the colon case at the lowest
magnetic flux density after 5min of continuous exposure
appears to be safe in all tissues, even neglecting thermo-
regulation, whether the prosthesis is present or not, regard-
less of the biomaterial chosen. On the contrary, for the
prostate treatment the presence of the prosthesis has to be
handled with caution even at the lowest field intensity, espe-
cially at bone level. Furthermore, this is also shown in the
data obtained from the thermoregulation model after 30min
exposure also for a magnetic field of 5mT (Supplementary
Figure S3(b)). Nevertheless, although DT increases always
with the presence of a prosthesis, it is central to work out
whether this effect may produce an irreversible damage to
the patient beyond the reported discomfort caused by a
temperature increase [2]. For such a purpose, the proposed
coupled plot-table can play a key role in multivariate deci-
sion trees to conclude if the therapy is safe: being comple-
mented, among others, with CEM43 estimators and
thermoregulatory tissue effects, which were not considered
in some cases due to the range of applicability of the
applied thermoregulation model when solving the heat
exchange problem. This implies that DT has been overesti-
mated in some of these analyses, for instance, in the prostate
case. The physiological effects due to heat generated along
the exposure time also have to be addressed according to its
Figure 3. Different views of the 3 D scatter plot of the magnetic flux density through the prosthesis voxels, the increment of temperature for these voxels and the
closest distance to the coil for the three cases studied: (a) 3 D view, (b) XY view, (c) XZ view, and (d) YZ view.
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threshold for thermal damage [73]. This will verify if the
extreme temperature values reached in a particular tissue
implies temporary, permanent or no damage at all.
The analysis puts in evidence that in all situations with
and without prosthesis, the field application related to the
prostate tumor may lead to the occurrence of some thermal
hot spots also without metallic parts. The relative low dis-
tance from the field source explains this result, shown in the
plots as a concentration of red dots in the upper-rightmost
region of the cloud of points.
For the colon case, the SAR limit is rarely exceeded, even
if hazardous temperature increases take place. For the three
field intensities, the majority of points in quadrant C show
middle distances to the coil, confirming that the calculated
DT for these voxels is due to heat diffusion from the pros-
thesis. In addition, there are not large differences between
the SAR value distributions with and without prosthesis
proving that the heat increase is not due to the direct power
deposition in the tissue.
Even if the shape of the voxel distributions in the SAR – DT
–plane is similar for the two alloys, both SAR and DT are found
to be higher for the hip prosthesis made by Ti6Al4V with
respect to the ones of CoCrMo, even if the electrical conductiv-
ity of the titanium alloy is about one half of that of CoCrMo.
Such a behavior, which may appear as surprising, occurs in
high conductivity materials when the skin effect becomes rele-
vant. This aspect is discussed in more detail and justified in
Supplementary Appendix F using a simplified model problem.
3.3. Analysis of the source position with respect to the
hip prosthesis
The outcome of the previous analysis for the colon and prostate
cases was scaled to have the same field intensity equal to 5mT in
Figure 4. Log-log scatter plots representing the DT and SAR of bone voxels for a dental implant studied with and without the metal-ceramic crown attached to it
both exposed for 30min to the same applied ac field with f¼ 300 kHz and 15mT. The thresholds are established according to ICNIRP 2020 guidelines for type 1 tis-
sues, namely DT¼ 5 C and SAR ¼ 10W/kg.
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the closest area of the skin to the source. Since SAR, strictly speak-
ing, is defined in biological tissues only, in the scatter plots, which
include only the prosthesis voxels, the magnetic flux density B
was used instead. The DT-B relationship was complemented with
the minimum distance to the source, obtaining a 3D scatter plot.
Figure 3 shows the 3D scatter plot for the prosthesis made of
Ti6Al4V, comparing the results of the treatment of colon and pros-
tate tumors with the ones of the worst-case scenario, where the
highest B values are expected due to its proximity to the field
source. As can be seen, if the source is placed far enough from
the implant while guaranteeing a sufficient H at the region to
treat, the probability of achieving a treatment within the safety
standards for thermal therapies is much higher.
3.4. Analysis of the dental implant
The effects of the dental implant on the bone tissue, the
closest to the implant, after a continuous exposure of 30min
are presented in Figure 4 and Table 3 following the same
procedure as for the hip prosthesis. For this analysis, only a
magnetic flux density value of 15mT in the neck region was
applied, accounting for the thermoregulation effects. This
data gives an evaluation of the impact due to the presence
of the metal ceramic crown.
Table 3 clearly shows the improvement on the safety
parameters considered when the metal ceramic crown is
removed. Indeed, the shielding effect of the ceramic coat-
ing of the crown produces a temperature increase within
the implant, and therefore, in the surrounding tissues.
In some points, especially when the crown is not
removed, the SAR threshold is exceeded. Despite these
risky points, the percentage of bone voxels in potentially
unsafe quadrants is very low (above 90% are in quadrant
A in all the cases studied) in comparison with the results
for the hip. Moreover, this scenario for dental implant is
much less critical than the two other clinical treatments
Figure 5. Slice Z normal views: (a) of the effective magnetic field for the worst-case scenario with and without prosthesis for an ac field with 5mT at skin level;
and (b) of the difference between effective magnetic field for the worst-case scenario with and without Ti6Al4V prosthesis. The alteration due to the generated
field drops to values around 0.1mT for distances below 1 cm away from the implant.
Table 3. Percentage of bone tissue voxels that fall within each quadrant in Figures 4, Supplementary Figures S5 and S6 plots.
Quadrant
RiskA B C D
With thermoregulation 5min exposure 5mT With crown 99.90% 0.10% 0.00% 0.00% 0.06 (S)
Without crown 99.92% 0.08% 0.00% 0.00% 0.06 (S)
10mT With crown 98.83% 0.00% 1.05% 0.12% 0.06 (S)
Without crown 99.88% 0.04% 0.02% 0.06% 0.06 (S)
15mT With crown 97.03% 0.00% 2.85% 0.12% 0.07 (S)
Without crown 98.95% 0.00% 0.95% 0.10% 0.06 (S)
30min exposure 5mT With crown 99.99% 0.01% 0.00% 0.00% 0.06 (S)
Without crown 99.99% 0.01% 0.00% 0.00% 0.06 (S)
10mT With crown 98.62% 0.00% 1.26% 0.12% 0.06 (S)
Without crown 99.86% 0.03% 0.04% 0.06% 0.06 (S)
15mT With crown 96.57% 0.00% 3.31% 0.12% 0.07 (S)
Without crown 98.87% 0.00% 1.03% 0.10% 0.06 (S)
Without thermoregulation 5min exposure 5mT With crown 99.90% 0.10% 0.00% 0.00% 0.06 (S)
Without crown 99.92% 0.08% 0.00% 0.00% 0.06 (S)
10mT With crown 96.91% 0.00% 2.97% 0.12% 0.07 (S)
Without crown 99.65% 0.02% 0.26% 0.07% 0.06 (S)
15mT With crown 91.86% 0.00% 8.02% 0.12% 0.09 (S)
Without crown 97.40% 0.00% 2.51% 0.10% 0.07 (S)
Risk column color indicates the safety of each case according to expression (5), the darker, the riskier; and a letter that indicates the risk: (S), safe; (A), accept-
able; (R), risky; (VR), very risky.
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analyzed above, even though the magnetic flux density is
similar to the case of the hip prosthesis for the same ac
field setup. This suggests that the volume of the metallic
part significantly influences the safety of treatment.
Further information about these results can be found in
Supplementary Figures S5, S6 and Table S10 and in
Ref. [66].
3.5. Influence of prostheses on the treated region
The significant eddy currents induced in metallic objects
generate a secondary magnetic field that could distort the
effective field produced by the applicator in the tissues as
well as in the nanoparticles under the hyperthermia treat-
ment. In order to verify how this alteration could affect the
treatment efficacy, the effective magnetic field distributions
Figure 6. (a) DT evolution over time for the three considered field intensities (5, 10 and 15mT), for the same indication (colon cancer case), and the same prosthesis
type (Ti6Al4V hip implant). Each curve tracks the temperature evolution for (i) the first voxel in surpassing the ICNIRP DT threshold, (ii) the global maximum of DT in
tissue at all times, and (iii) the globalmaximum of DT in the prosthesis at all times. (b) DT evolution over time for the two prosthesis materials considered (Ti6Al4V and
CoCrMo), for the same indication (colon cancer case), under the same field conditions (15mT, 300 kHz). Each curve tracks the temperature evolution for (i) the first
voxel in surpassing the ICNIRP DT threshold, (ii) the global maximum of DT in tissue at all times, and (iii) the global maximum of DT in the prosthesis at all times.
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in the radiated region with and without the prosthesis are
compared in Figure 5(a). This study was performed for the
Ti6Al4V hip prosthesis in the worst-case scenario, where the
most intense secondary field is expected because the dis-
tance between coil and prosthesis is the shortest and the
power deposition is the highest. The ac field applied was set
up for f¼ 300 kHz and 5mT at the skin level. The comparison
shows that the highest differences are localized in a limited
space very near to the prosthesis and drop very fast with the
distance (Figure 5(b)), without affecting the region under
treatment. The field variation starts to be negligible 1–2 cm
away from the metallic surface and reaches a maximum
intensity of 1mT in the area closest to the surface of the
prosthesis. As a rule of thumb, the secondary field produced
by eddy currents should not affect the hyperthermia treat-
ment – with the exception of the hypothetical case where
the tumor, and hence the injected nanoparticles, were in
close contact with the prosthesis.
Since the magnetic field intensity decays as the distance
to the source increases, SAR in tissues will also decrease and,
consequently, so will do DT. In order to minimize undesired
effects, the easiest ways would seem a change of the source
position. However, if the coil is just moved farther from the
region of interest, the field intensity of the source has to be
increased to guarantee a sufficient heating up of the nano-
particles at the tumor site. By doing so, a wider area would
become exposed to a more homogenous field. If the source
is far enough, the field applied in the surrounding area could
reach an intensity close to the one of the treatment region,
so too high to be safe in the presence of a metallic implant.
As the displacement of the source might not be a solution in
some cases, other strategies should be studied, such as
diverse coil designs or different field intensity and frequency
pair values, for instance.
Besides knowing the absolute maximum temperatures
that are reached in the different tissues, it is also important
to know the rate at which these values are attained during
the treatment. This information allows an adequate refine-
ment of the treatment planning process by selecting the
conditions necessary to reach a therapeutic temperature at
the tumor site as homogeneously as possible without signifi-
cant thermal damage to healthy tissues. Figure 6 is an exem-
plary representation of the evolution of DT over time for a
given indication, under different field conditions, and for dif-
ferent prosthesis materials. Each curve tracks the tempera-
ture evolution for (i) the voxel with the lowest value in the
set of those that surpass the ICNIRP DT threshold at the
earliest time point, (ii) the global maximum of DT in tissue at
all times, and (iii) the global maximum of DT in the relevant
prosthesis at all times. It has to be noted that the voxel with
the lowest value in the set of those that surpass the ICNIRP
DT threshold in Figure 6(a,b) has been obtained as the aver-
age of the five voxels with the lowest values surpassing the
ICNIRP DT threshold (for more details see Supplemental
Material). Although the temperature increase is faster in pros-
theses rather than in tissues, thermal equilibrium in the pros-
theses is reached 30 s later than in the tissues for all the field
conditions and materials here studied (Table 4). The equilib-
rium time point appears later for increasing field intensity
values (Figure 6(a), Table 4). Under identical conditions,
Ti6Al4V prostheses heat up quicker than CoCrMo ones, fea-
ture a higher DT and also reach thermal equilibrium at
shorter times (Figure 6(b)). There are some cases where the
curve for the first voxel with DT¼ 5 C takes shorter times to
reach the thermal equilibrium. This depends on the relative
position of the voxel itself with respect to the prosthesis. The
latter is the main heat source; so, as we get away from the
metallic object, its contribution to temperature rise is dif-
fused. Therefore, the closer to the metallic object, the longer
times will take to reach the thermal equilibrium. The
observed relationship between time to thermal equilibrium
and overall treatment time (30min) may be similar to that
between time to therapeutic temperature and overall treat-
ment time. The time elapsed until the maximum therapeutic
effect is achieved in the treated region, the effective thera-
peutic time, is almost the half of the overall 30-min treat-
ment time.
These curves also reveal how quickly a particular set of
conditions may cause harm to tissues adjacent to the pros-
theses. In principle, such damage may occur in as much and
as long as they surpass the recommended thresholds by the
ICNIRP. This is particularly important for high intensity values,
since thermal thresholds may be exceeded from the begin-
ning of the treatment and maximum temperatures may be
reached before the therapeutic temperature is attained at
the tumor site.
Only data at the highest field intensity is shown here to
provide a better insight in the safety issues. Nevertheless,
the obtained data for the remaining indications under lower
field intensities are freely available in the supplementary
information [66]. In those cases, there is a variable time
period before the thermal thresholds start to be surpassed.
4. Conclusions
We have presented a methodology aimed to revise and
improve the current exclusion criteria applied to implant-
bearing patients in magnetic hyperthermia treatments,
increasing their chances of inclusion and hence the access to
a better quality of life. The studied prostheses heat up in all
the tested field conditions, which include a range of relevant
Hf values, in some cases higher than those used in clinical
trials and thus providing a good case for risk estimation. We
have established that the secondary field produced by eddy
currents at the surface of the implants creates a maximum
Table 4. Main parameters from the curves featured in Figure 6 (threshold
DT¼ 5 C, maximum temperature in tissue, and maximum temperature
in prosthesis).
Time (s)
Figure 6(a) (Ti6Al4V) Figure 6(b) (15mT)
Parameter 5mT 10mT 15mT Ti6Al4V CoCrMo
Threshold DT¼ 5 C 540 690 930 930 1020
Maximum temperature in tissue 540 690 870 870 990
Maximum temperature in prosthesis 570 720 900 900 1020
The reported time values are those so that the derivative of the temperature
vs time curves is less than 0.001 s.
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distortion of about 1–2 cm thick just around the hip joint,
which in practical terms means that the effective field keeps
unperturbed for most of the radiated regions.
We have seen that thermal equilibrium at both the pros-
thesis and tissues is reached at a time point ranging from
540 s to 1020s, depending on the combination of field condi-
tions and choice of prosthesis material. Consequently, the
effective therapy time at the desired temperature may be
actually the half of the overall one, and thus this transient
period toward thermal equilibrium should be carefully
appraised during treatment planning. Besides the method-
ology for predicting prosthesis heating, we propose a quick
screening method based on calculated SAR and temperature
data plotted in a log-log graph, which in turn is divided in
four quadrants, each representing different levels of severity
of tissue damage. Of particular note is that the proposed
methodology allowed to discern the basic underlying mecha-
nisms to the temperature elevation (field-tissue interaction,
heat exchange from field-implant interaction) over the
treated region. Whereas for some conditions – for example,
prostate cancer at 15mT – the therapy is rendered unsafe
given the high temperatures reached at bone tissues, for
others the therapy may be safe – for example, colorectal can-
cer at 5mT for any type of implant biomaterial. In any case,
the benefit/risk ratio of undergoing the procedure under
some given conditions must be carefully appraised by the
clinical staff. Our simulations have also established differen-
ces and similarities between the biomaterials from which the
implants were made.
Very likely, the current stringent admission criteria that
completely exclude implant-bearing patients is due to the
lack of systematic preclinical studies, both costly and com-
plex to be carried out in humans. Nevertheless, systematic in
silico treatment planning, backed by an adequate method-
ology, can help in recovering for this minimally invasive ther-
apy those otherwise excluded patients who could benefit
greatly from it.
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The whole dataset obtained during the course of this study is publicly
available for download. The files are uploaded in the Zenodo repository
under the title ‘Dataset from “In silico assessment of collateral eddy cur-
rent heating in biocompatible implants subjected to magnetic hyper-
thermia treatments”.’ The structure of the files is also explained [66].
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